Debra R. Lappin, JD

Debra Lappin is recognized across government, academic and nonprofit sectors as a leading strategist in public health and science policy. She consults on innovative public-private partnerships, global consortia and other strategic alliances among academic research institutions, voluntary health agencies, government and industry. Calling upon her experiences as former national chair of the Arthritis Foundation, Debra is a recognized national spokesperson on public engagement in the nation's public health and scientific enterprise.

Debra's practice focuses on the changing roles of academia research institutions and the increasing influence of venture philanthropic patient organizations in accelerating translational research. She is recognized for her leadership of major science policy campaigns calling for public access to scientific communications and genetic non-discrimination. Drawing upon her understanding of health agency trends, law, ethics and practical business challenges, Debra advises on the development of a broad range of emerging, complex tools to enable translation, such as disease registries, large integrated databases, bio-specimen repositories and cross-institution affiliations, to share data.

Debra serves or has served as an advisor to the leading agencies in public health, including the Centers for Disease Control and Prevention and the National Institutes of Health. She has participated on a number of committees at the National Academy of Sciences, including the Committee on the Organizational Structure of the NIH which led to a number of directions incorporated in the 2006 NIH Reform Act. Debra is President of the Council for American Medical Innovation, a member of the Board of Research!America and an adjunct professor at the University of Colorado Health Sciences Center.